The Drug Enforcement Administration (DEA) has agreed to loosen its restrictions on cannabis, sparking discussions about the rescheduling of marijuana. The move could potentially bring significant changes to the cannabis industry, with implications for state markets and federal law compliance. Various stakeholders, including Congressional researchers and legal experts, are examining the impact of this decision, including the potential reclassification of marijuana and tax benefits that may arise. Questions remain about how the rescheduling process will unfold and what it means for marijuana businesses moving forward.